An Open Label Pilot Study to Evaluate the Effect of KB195, a Novel Prebiotic Gluco-Oligosaccharide Mixture, in the Diet of Patients With Urea Cycle Disorders on Gut Nitrogen Metabolism
Latest Information Update: 10 Jan 2020
At a glance
- Drugs Onterodrimer (Primary)
- Indications Hyperammonaemia; Inborn urea cycle disorders
- Focus Therapeutic Use
- Sponsors Kaleido Biosciences
Most Recent Events
- 03 Sep 2019 Status changed from recruiting to completed, according to a Kaleido Biosciences media release.
- 03 Sep 2019 According to a Kaleido Biosciences media release, results from the study were presented in a poster presentation during the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2019.
- 03 Sep 2019 Results presented in a Kaleido Biosciences media release.